Biotech Blog Archives: March 2004
·
previous page
8 March 2004
Biotech uptick moves into March
Biotech uptick moves into March:
“February went out like a lion in biotechnology as filings for initial public offerings (IPOs) by three companies capped a flurry of activity in the sector. Acadia Pharmaceuticals, Alnylam Pharmaceuticals, and Ark Therapeutics announced filings in the wake of strong openings on Wall Street last month for GTx, Renovis, Corgentech, and [...]
continue reading... » 0 Comments
3 March 2004
And When ImClone’s Drug Doesn’t Work…
And When ImClone’s Drug Doesn’t Work…
It’s not all roses for Erbitux: “The drug dramatically shrinks colon tumors in some patients. But in others, it has little effect — and no one knows why. “
